335 related articles for article (PubMed ID: 18321744)
1. Tolerability of high cumulative doses of the HFA modulite beclomethasone dipropionate/formoterol combination inhaler in asthmatic patients.
Singh D; Piccinno A; Borrill Z; Poli G; Acerbi D; Meuleners L; Woodcock A
Pulm Pharmacol Ther; 2008; 21(3):551-7. PubMed ID: 18321744
[TBL] [Abstract][Full Text] [Related]
2. Extrafine beclomethasone/formoterol combination via a dry powder inhaler (NEXThaler(®)) or pMDI and beclomethasone monotherapy for maintenance of asthma control in adult patients: A randomised, double-blind trial.
Kanniess F; Scuri M; Vezzoli S; Francisco C; Petruzzelli S
Pulm Pharmacol Ther; 2015 Feb; 30():121-7. PubMed ID: 25088067
[TBL] [Abstract][Full Text] [Related]
3. Rapid effects of extrafine beclomethasone dipropionate/formoterol fixed combination inhaler on airway inflammation and bronchoconstriction in asthma: a randomised controlled trial.
O'Connor BJ; Collarini S; Poli G; Brindicci C; Spinola M; Acerbi D; Barnes PJ; Leaker B
BMC Pulm Med; 2011 Dec; 11():60. PubMed ID: 22188731
[TBL] [Abstract][Full Text] [Related]
4. Lung function and asthma control with beclomethasone and formoterol in a single inhaler.
Huchon G; Magnussen H; Chuchalin A; Dymek L; Gonod FB; Bousquet J
Respir Med; 2009 Jan; 103(1):41-9. PubMed ID: 18977646
[TBL] [Abstract][Full Text] [Related]
5. A randomized, double-blind, double-dummy, safety crossover trial comparing cumulative doses up to 96 microg of formoterol delivered via an HFA-134a-propelled pMDI vs. same cumulative doses of formoterol DPI and placebo in asthmatic patients.
Molimard M; Guenolé E; Duvauchelle T; Vicaut E; Lefrançois G
Respiration; 2005; 72 Suppl 1():28-34. PubMed ID: 15915010
[TBL] [Abstract][Full Text] [Related]
6. Real-life effectiveness of extrafine beclometasone dipropionate/formoterol in adults with persistent asthma according to smoking status.
Brusselle G; Peché R; Van den Brande P; Verhulst A; Hollanders W; Bruhwyler J
Respir Med; 2012 Jun; 106(6):811-9. PubMed ID: 22357130
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetic comparison of inhaled fixed combination vs. the free combination of beclomethasone and formoterol pMDIs in asthmatic children.
Chawes BL; Piccinno A; Kreiner-Møller E; Vissing NH; Poorisrisak P; Mortensen L; Nilson E; Bisgaard A; Dossing A; Deleuran M; Skytt NL; Samandari N; Sergio F; Ciurlia G; Poli G; Acerbi D; Bisgaard H
Br J Clin Pharmacol; 2013 Apr; 75(4):1081-8. PubMed ID: 22978252
[TBL] [Abstract][Full Text] [Related]
8. Stepping-across controlled asthmatic patients to extrafine beclometasone/formoterol combination.
Barnes N; van Noord JA; Brindicci C; Lindemann L; Varoli G; Perpiña M; Guastalla D; Casula D; Patel S; Chanez P;
Pulm Pharmacol Ther; 2013 Oct; 26(5):555-61. PubMed ID: 23524015
[TBL] [Abstract][Full Text] [Related]
9. Real life clinical study design supporting the effectiveness of extra-fine inhaled beclomethasone/formoterol at the level of small airways of asthmatics.
Popov TA; Petrova D; Kralimarkova TZ; Ivanov Y; Popova T; Peneva M; Odzhakova T; Ilieva Y; Yakovliev P; Lazarova T; Georgiev O; Hodzhev V; Hodzheva E; Staevska MT; Dimitrov VD
Pulm Pharmacol Ther; 2013 Dec; 26(6):624-9. PubMed ID: 23769863
[TBL] [Abstract][Full Text] [Related]
10. Beclometasone dipropionate/formoterol: in an HFA-propelled pressurised metered-dose inhaler.
Dhillon S; Keating GM
Drugs; 2006; 66(11):1475-83; discussion 1484-5. PubMed ID: 16906779
[TBL] [Abstract][Full Text] [Related]
11. A comparison of double-strength beclomethasone dipropionate (84 microg) MDI with beclomethasone dipropionate (42 microg) MDI in the treatment of asthma.
Nathan RA; Nolop KB; Cuss FM; Lorber RR
Chest; 1997 Jul; 112(1):34-9. PubMed ID: 9228354
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics and pharmacodynamics of an extrafine fixed pMDI combination of beclometasone dipropionate/formoterol fumarate in adolescent asthma.
Kuna P; Govoni M; Lucci G; Scuri M; Acerbi D; Stelmach I
Br J Clin Pharmacol; 2015 Sep; 80(3):569-80. PubMed ID: 25808292
[TBL] [Abstract][Full Text] [Related]
13. Systemic exposure and implications for lung deposition with an extra-fine hydrofluoroalkane beclometasone dipropionate/formoterol fixed combination.
Bousquet J; Poli G; Acerbi D; Monno R; Ramael S; Nollevaux F
Clin Pharmacokinet; 2009; 48(6):347-58. PubMed ID: 19650674
[TBL] [Abstract][Full Text] [Related]
14. Beclometasone-formoterol as maintenance and reliever treatment in patients with asthma: a double-blind, randomised controlled trial.
Papi A; Corradi M; Pigeon-Francisco C; Baronio R; Siergiejko Z; Petruzzelli S; Fabbri LM; Rabe KF
Lancet Respir Med; 2013 Mar; 1(1):23-31. PubMed ID: 24321801
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the bronchodilator and systemic effects of AZD3199, an inhaled ultra-long-acting β₂-adrenoceptor agonist, with formoterol in patients with asthma.
Bjermer L; Rosenborg J; Bengtsson T; Lötvall J
Ther Adv Respir Dis; 2013 Oct; 7(5):264-71. PubMed ID: 23907810
[TBL] [Abstract][Full Text] [Related]
16. Treatment of persistent asthma with Symbicort (budesonide/formoterol inhalation aerosol): an inhaled corticosteroid and long-acting beta2-adrenergic agonist in one pressurized metered-dose inhaler.
Berger WE; Noonan MJ
J Asthma; 2010 May; 47(4):447-59. PubMed ID: 20528601
[TBL] [Abstract][Full Text] [Related]
17. Ethnic Sensitivity Study of the Extrafine, Single-Inhaler, Triple Therapy Beclomethasone Dipropionate, Formoterol Fumarate, and Glycopyrronium Bromide Pressurized Metered Dose Inhaler in Japanese and Caucasian Healthy Individuals: A Randomized, Double-Blind, Single-Dose Crossover Study.
Cella M; Täubel J; Delestre-Levai I; Tulard A; Vele A; Georges G
Clin Ther; 2021 Nov; 43(11):1934-1947.e4. PubMed ID: 34600734
[TBL] [Abstract][Full Text] [Related]
18. Budesonide/formoterol for maintenance and relief in uncontrolled asthma vs. high-dose salmeterol/fluticasone.
Bousquet J; Boulet LP; Peters MJ; Magnussen H; Quiralte J; Martinez-Aguilar NE; Carlsheimer A
Respir Med; 2007 Dec; 101(12):2437-46. PubMed ID: 17905575
[TBL] [Abstract][Full Text] [Related]
19. Safety and efficacy of fluticasone and beclomethasone in moderate to severe asthma. Belgian Multicenter Study Group.
Pauwels RA; Yernault JC; Demedts MG; Geusens P
Am J Respir Crit Care Med; 1998 Mar; 157(3 Pt 1):827-32. PubMed ID: 9517598
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of once or twice daily inhalation of extrafine HFA beclomethasone dipropionate in patients with mild to moderate asthma.
Gillissen A; Richter A; Oster H; Criée CP
J Physiol Pharmacol; 2007 Nov; 58 Suppl 5(Pt 1):233-41. PubMed ID: 18204133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]